Editorial
 EXORBITANT CHARGES BY HOSPITALS   
 Wednesday, July 1, 2020 
 The issue of exorbitant and prohibitive prices being charged by the private healthcare institutions from the COVID-19 patients has been hitting the headlines ever since the COVID-19 pandemic started spreading in the country in April this year. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Menarini Ricerche to launch phase Ib/II C-PRECISE-01 trial of MEN1611 to treat metastatic colorectal cancer
17:40  [IST]Thyrocare launches ‘COVID Antibody Test’
17:30  [IST]AstraZeneca’s dapagliflozin receives DCGI marketing approval to treat patients with heart failure
17:00  [IST]EMA approves CSL Behring’s novel, long-acting recombinant albumin fusion protein, Idelvion to treat for haemophilia B
16:30  [IST]Merck enters agreement with Janssen to develop AI based diagnostic tool for neglected tropical diseases
16:00  [IST]Liminal BioSciences joins CoVIg Plasma Alliance to speed up development of potential new COVID-19 therapy
more news >>
TOP NEWS
08:00  [IST]Tanzania allows drug exporters to modify specifications of registered medicinal products
08:00  [IST]Indian pharma and biotech sectors need to create innovation stream roping in academia to propel research
08:00  [IST]Suppliers still await Haffkine’s response on pending bid of March 14 for purchase of 10 RT–PCR machines for COVID-19 diagnosis in Maharashtra
08:00  [IST]Delay in getting registered with state pharmacy council not to affect running of medical shops in J&K and Ladakh: JKPC
08:00  [IST]CCMB researchers identify A2A and A3I coronavirus strains widely spreading across India
08:00  [IST]IMA urges health secretary, MCI to allow NEET-PG aspirants to take part in Mop-up round of counselling
more news >>
YESTERDAY'S NEWS
18:00  [IST]NIH-funded study finds complexity of human tooth enamel revealed at atomic level
17:45  [IST]Transcenta begins patient dosing in phase I trial of Claudin18.2 targeting monoclonal antibody TST001 in US
17:30  [IST]US FDA grants rare pediatric disease status to Rhythm’s setmelanotide to treat POMC and LEPR deficiency obesities
17:15  [IST]MTaI urges government to release stalled imports of medical devices
16:50  [IST]Union health ministry issues revised home isolation guidelines for COVID-19
16:40  [IST]Delhi, Mumbai on route to recovery from COVID-19, says Dr K K Aggarwal
more news >>
INTERVIEW  
Med-tech ramps up accurate diagnosis with AI and algorithms
120287Ayelet_Interview Dr Ayelet Akselrod-Ballin, director of AI, Zebra Medical Vision
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the DoP's recent amendment to Para 32 of DPCO to provide 5-year price control exemption to patented innovative & rare diseases drugs a right move to increase accessibility ?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
VFA2020_EP_WB_150x60px_FA.jpg
Gandhi_auto_2019_Panel
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |